We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02927080
Recruitment Status : Recruiting
First Posted : October 6, 2016
Last Update Posted : March 16, 2018
Information provided by (Responsible Party):
Acceleron Pharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2020
  Estimated Study Completion Date : May 2020